Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion type Assertion NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_head.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion description "[Despite the evidence of early insulin treatment lowering macrovascular (coronary artery disease, peripheral arterial disease and stroke) and microvascular (diabetic nephropathy, neuropathy and retinopathy) complications of T2DM, controversy exists among physicians on how to initiate and intensify insulin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_provenance.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion evidence source_evidence_literature NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_provenance.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion SIO_000772 23584214 NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_provenance.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion wasDerivedFrom befree-20150227 NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_provenance.
- NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_assertion wasGeneratedBy ECO_0000203 NP1006471.RA4obZVnI4CUzZFC08oATPVTGdkL5jLZ7i7N8vSKS8wlA130_provenance.